Products
| Strength | 1 mg, 20 mg, 100 mg |
|---|---|
| Volume | 2 ml |
| ATC code | A11DB |
VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12
This medicine is used for treatment of haematologic and neurologic symptoms caused by continuous deficiency of vitamins B1, B6 and B12 in adults and children over 12 years.
Prescription medication. Information for healthcare professionals only.
For full information about the medicine, see the Summary of Product Characteristics.
Advertising developed or revised (06.2020). Advertiser: JSC Kalceks
| Strength | 100 mg/ml, 200 mg/ml, 250 mg/ml |
|---|---|
| Volume | 10 ml |
| ATC code | A12CC02 |
Other mineral supplements
Additional Strength: 500 mg/ml (WHO prequalified) 2 ml and 10 ml
This medicine is used for:
- Treatment and prevention of hypomagnesaemia in clinical conditions which may be associated with magnesium deficiency such as prolonged diarrhoea, diabetes mellitus, malabsorption syndromes, alcoholism, cirrhosis of the liver, during pregnancy and breast-feeding period, in case of renal diseases with polyuria, as well as during administration of “loop” diuretics;
- Prevention and treatment of hypomagnesaemia in patients on total parenteral nutrition;
- Seizure prevention (e. g. epilepsy, uraemia in patients with nephropathy);
- Prevention and treatment of pre-eclampsia and eclampsia in late pregnancy toxemia, as well as to stop spontaneous abortion and preterm labour;
- Treatment of the early stages of arterial hypertension as antispasmodic medicine;
- Prevention of arrhythmias (e. g. torsade de pointes-type arrhythmias, arrhythmias with signs of hypokalemia).
Prescription medication. Information for healthcare professionals only.
For full information about the medicine, see the Summary of Product Characteristics.
Advertising developed or revised (06.2020). Advertiser: JSC Kalceks
| Strength | 50 mg/ml |
|---|---|
| Volume | 1 ml |
| ATC code | A11HA02 |
VITAMINS, OTHER PLAIN VITAMIN PREPARATIONS
This medicine is indicated for:
- Vitamin B6 deficiency (including in patients on dialysis);
- sideroblastic anaemia (congenital, secondary, drug- and toxin-induced and other);
- metabolic disorders (increased excretion of xanthurenic acid, primary cystathioninuria, primary hyperoxaluria, primary homocystinuria);
- isoniazid-induced neuropathy; - pyridoxine-dependent seizures in infants;
- premenstrual syndrome.
Prescription medication. Information for healthcare professionals only.
For full information about the medicine, see the Summary of Product Characteristics.
Advertising developed or revised (06.2020). Advertiser: JSC Kalceks
| Strength | 9 mg/ml |
|---|---|
| Volume | 10 ml |
| ATC code | B05XA03 |
BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS, I.V. SOLUTION ADDITIVES
This medicine is used for dissolution or dilution of parenteral drugs. For the wounds, mucous membrane and eyes irrigation.
Prescription medication. Information for healthcare professionals only.
For full information about the medicine, see the Summary of Product Characteristics.
Advertising developed or revised (06.2020). Advertiser: JSC Kalceks
| Volume | 10 ml |
|---|---|
| ATC code | V07AB |
ALL OTHER NON-THERAPEUTIC PRODUCTS
This medicine is used for dissolution or dilution of parenteral drugs. Vehicle for administration of compatible drug and electrolyte concentrate,
observing that the osmolarity of whole solution corresponds to 0.85-0.9 % of osmolarity of sodium chloride solution.
Prescription medication. Information for healthcare professionals only.
For full information about the medicine, see the Summary of Product Characteristics.
Advertising developed or revised (06.2020). Advertiser: JSC Kalceks